Tetsuya Kamataki
Division of Drug Metabolism
Faculty of Pharmaceutical Sciences
Hokkaido University
N12W6
Japan
Name/email consistency: high
- Role of human cytochrome P450 (CYP) in the metabolic activation of nitrosamine derivatives: application of genetically engineered Salmonella expressing human CYP. Kamataki, T., Fujita, K., Nakayama, K., Yamazaki, Y., Miyamoto, M., Ariyoshi, N. Drug Metab. Rev. (2002)
- Establishment of a Salmonella tester strain highly sensitive to mutagenic heterocylic amines. Kamataki, T., Suzuki, A., Kushida, H., Iwata, H., Watanabe, M., Nohmi, T., Fujita, K. Cancer Lett. (1999)
- Genetic polymorphism of CYP2A6 in relation to cancer. Kamataki, T., Nunoya, K., Sakai, Y., Kushida, H., Fujita, K. Mutat. Res. (1999)
- Inhibition of the transcription of CYP1A1 gene by the upstream stimulatory factor 1 in rabbits. Competitive binding of USF1 with AhR.Arnt complex. Takahashi, Y., Nakayama, K., Itoh, S., Fujii-Kuriyama, Y., Kamataki, T. J. Biol. Chem. (1997)